Presentation

Company Profile
BioGaia is a Swedish healthcare firm founded in 1990 with nearly 30 years of experience within the field of probiotic products. The company has about 160 employees and offices in Sweden, the US as well as Japan Singapore and South Africa. BioGaia engages in the development, marketing, and sale of probiotic products with documented health benefits. The portfolio consists of 555 patents in 30 families and the products are sold in 100 different markets through distributors.

Recent highlights
In the first half of 2021, Net sales amounted to SEK 405.1 million (427.5), a decrease of 5% (excluding foreign exchange effects, +5%). In April BioGaia announced that the company has signed an agreement with Minapharm Pharmaceuticals for exclusive rights to sell BioGaia Protectis drops in Egypt. In April, BioGaia also announced that a randomised, double-blind, placebo-controlled study in children showed that a supplement of two L. reuteri strains significantly reduced fever and pain in children with upper respiratory tract infections. In May, the company announced that BioGaia’s products will be sold under the BioGaia brand in Finland.

Outlook
The company will continue to implement their omni-channel strategy, with strong focus in science and marketing. Aiming to increase their market share and awareness of the brand, BioGaia has established a new department, BioGaia Digital.